Arthur Riggs Diabetes & Metabolism Research Institute Newsroom

It is essential that patients with diabetes learn to identify the subtle warning signs of foot issues and to take action early, says City of Hope’s Paul Han, D.P.M., M.S.

Key City of Hope studies center around ways to potentially reduce hypoglycemic episodes, why men might be more susceptible to diabetes than women, and new targets to improve beta cell function and glucose control

With hematologist Amrita Krishnan, M.D., tackling her multiple myeloma and endocrinologist Ping H. Wang, M.D., addressing her type 2 diabetes, retired educator Julie Hilberg continues to thrive

In 2004, Susan Weinberg became the first patient at City of Hope to receive the experimental treatment for type 1 diabetes. She is now insulin-free and considered nondiabetic

Adolfo Garcia-Ocaña, Ph.D., has joined City of Hope as the new chair of the Department of Molecular & Cellular Endocrinology. He has dedicated his career to studying the mechanisms that drive beta cell health

The renowned scientist is the newest addition to City of Hope’s growing commitment to stamp out type 1 diabetes, taking over the Wanek Family Project and chairing the Department of Diabetes Immunology

Arthur D. Riggs, Ph.D., the world-renowned diabetes expert who developed the technology that led to the first human synthetic insulin for the treatment of diabetes, died March 23 after battling cancer.